Pre-vaccination care-seeking in females reporting severe adverse reactions to HPV Vaccine. A registry based case-control study

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Mølbak, Kåre ^a   Hansen, Niels Dalum ^b,c   Valentiner Branth, Palle ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c IBM Inc   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; ANKLE SPRAIN; ANUS FISSURE; ARTICLE; CASE CONTROL STUDY; CHILD; CHONDROMALACIA; CHRONIC OSTEOMYELITIS; COLLAPSE; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; DRUG SAFETY; DYSPEPSIA; ENTEROPATHY; FAINTNESS; FEMALE; GALLBLADDER DISEASE; GASTROESOPHAGEAL REFLUX; HEALTH CARE SURVEY; HEALTH PROGRAM; HELP SEEKING BEHAVIOR; HUMAN; IRRITABLE COLON; JOINT DISLOCATION; JUVENILE RHEUMATOID ARTHRITIS; LIMB PAIN; MAJOR CLINICAL STUDY; MAXILLA HYPOPLASIA; MORBIDITY; MUSCLE STRAIN; PATIENT-REPORTED OUTCOME; PELVIC PAIN; PRIMARY HEALTH CARE; PSORIATIC ARTHRITIS; RECTUM HEMORRHAGE; SHOULDER DISEASE; TELECONSULTATION; TENNIS ELBOW; VACCINATION; ADVERSE EFFECTS; DIGESTIVE SYSTEM; DRUG EFFECTS; MIDDLE AGED; MUSCULOSKELETAL SYSTEM; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; DIGESTIVE SYSTEM; FEMALE; HUMANS; MIDDLE AGED; MUSCULOSKELETAL SYSTEM; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; REGISTRIES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84990985699     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162520     Document Type: Article

References (22)

1. The Danish Health Authority, the Danish Medicines Authority and Statens SerumInstitut. Annual reportson the Danish childhood vaccination programme. Statens SerumInstitut: EPI-NEWS 17/2016. Available: http://www.ssi.dk/English/News/EPI-NEWS/2016/No%2017%20-%202016.asp. Accessed 1 July 2016.
2. Report from the Danish Health and Medicines Authority for consideration by EMA and rapporteurs in relation to the assessment of the safety profile of HPV-vaccines. 2015. Available: http://sundhedsstyrelsen.dk/~/media/0A404AD71555435BB311CD59CB63071A.ashx. Accessed 1 July 2016.
3. Brinth L, Theibel AC, Pors K, Mehlsen J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 2015; 62: A5064. PMID: 25872549
4. Brinth L, Pors K, Hoppe A-AG, Badreldin I, Mehlsen J. Is chronic fatigue syndrome/myalgic encephalomyelitis a relevant diagnosis in patients with suspected side effects to human papilloma virus vaccine? Int J Vaccines and Vaccination 2015; 1: 1.
5. Kinoshita T, Abe RT, Hineno A, Tsunekawa K, Nakane S, Ikeda S. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine. InternMed 2014; 53: 2185-200. PMID: 25274229
6. Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency. Assessment report.Review under Article 20 of Regulation (EC) No 726/2004, human papillomavirus (HPV) vaccines. EMA/762033/2015. 2015. Available: http://www.ema.europa.eu/docs/en-GB/document-library/Referrals-document/HPV-vaccines-20/Opinion-provided-by-Committee-for-Medicinal-Products-for-Human-Use/WC500197129.pdf. Accessed 1 July 2016.
7. Global Advisory Committee on Vaccine Safety, 2-3 December 2015.Weekly Epid Rec 2016; 91: 21-32. Available: http://www.who.int/vaccine-safety/committee/reports/wer9103.pdf?ua=1. Accessed 1 July 2016.
8. Decline in the uptake of HPV vaccination. 2016. Available: http://www.ssi.dk/Aktuelt/Nyheder/2016/2016%201%20hpv-fald.aspx. Accessed 1 July 2016. In Danish.
9. Fonteneau L, Ragot M, Parent du ChǍtelet I, Guthmann JP, Lévy-Bruhl D. The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety. BMC Public Health 2015; 15: 1233. doi: 10.1186/s12889-015-2575-7 PMID: 26654908
10. Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet 2015; 385: 2571. doi: 10.1016/S0140-6736(15)61152-7.
11. Erratum in: Lancet 2015; 386: 248. PMID: 26122153
12. ICH Harmonised Tripartite Guideline for Clinical Safety Data Management: Definitions and Standards for expedited reporting.CPMP/ICH/377/95.EMEA 2006. Available: http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002749.pdf. Accessed 1 July 2016.
13. Grove Krause T, Jakobsen S, Haarh M,Mølbak K. The Danish vaccination register. Euro Surveill 2012; 17: pii: 20155. Available: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20155. Accessed 1 July 2016.
14. Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in primarycare: a comparison of self-reportscreening questionnaires and clinical opinion. J Psychosom Res 1997; 42: 245-52. PMID: 9130181
15. Reid S,Wessely S, Crayford T, Hotopf M. Medically unexplained symptoms in frequent attenders of secondary health care: retrospective cohort study. BMJ 2001; 322: 767. PMID: 11282861
16. The Danish Patient Compensation Association (Patienterstatningen). 2015. Available: http://patienterstatningen.dk/da/Nyheder/Nyhedsarkiv/HPV-september-2015.Accessed 1 July 2016. News item in Danish.
17. Callréus T, Svanström H, Nielsen NM, Poulsen S, Valentiner-Branth P, Hviid A. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events. Vaccine 2009; 27: 2954-8. doi: 10.1016/j.vaccine.2009.02.106 PMID: 19428906
18. Arnheim-Dahlström L, Pasternak B, Svanström H, Sparén P, Hviid A. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013; 347: f5906. doi: 10. 1136/bmj.f5906 PMID: 24108159
19. Scheller NM, Svanström H, Pasternak B, et al. Quadrivalent HPV vaccination and risk ofmultiple sclerosis and other demyelinating diseases of the central nervous system. JAMA 2015; 313: 54-61. doi: 10.1001/jama.2014.16946 PMID: 25562266
20. Cameron RL, Ahmed S, Pollock KG. Adverse event monitoring of the human papillomavirus vaccines in Scotland. InternMed J 2016;
21. Klein NP, Hansen J, Chao C, et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med 2012; 166: 1140-8. doi: 10.1001/archpediatrics.2012. 1451 PMID: 23027469
22. Donegan K, Beau-Lejdstrom R, King B, Seabroke S, Thomson A, Bryan P. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine 2013; 31: 4961-7. doi: 10. 1016/j.vaccine.2013.08.024 PMID: 24001935